VGHCX vs XLV

VGHCX is a mutual fund, whereas XLV is an ETF. VGHCX has a lower 5-year return than XLV (8.31% vs 10.66%). VGHCX has a higher expense ratio than XLV (0.32% vs 0.13%). Below is the comparison between VGHCX and XLV.

XLV VGHCX
Security Type ETF Mutual fund
Segment Equity: U.S. Health Care Specialty: Health
Issuer State Street Global Advisors Vanguard
Net Assets $25.75B $7.82B
Expense Ratio 0.13% 0.32%
Management Style passive (index-based) active
Dividend Yield 2.25% 1.17%
Minimum Investment N/A $3,000.00
YTD Return 8.25% 8.83%
1-Year Return 14.12% 14.07%
3-Year Return 12.45% 11.22%
5-Year Return 10.66% 8.31%
10-Year Return 15.38% 15.03%

VGHCX description

The Fund seeks capital appreciation by investing principally in the equity securities of companies in the health care industry.

VGHCX performance & returns

YTD Return 8.83%
1-Month Return 0.55%
3-Month Return 0.36%
1-Year Return 14.07%
3-Year Return 11.22%
5-Year Return 8.31%
10-Year Return 15.03%
VGHCX expense ratio is 0.32%.

VGHCX holdings

Top 10 Holdings (39.71% of Total Assets)

Name Symbol % Assets
UnitedHealth Group Inc UNH 5.66%
AstraZeneca PLC AZN.L 5.36%
Pfizer Inc PFE 4.98%
Bristol-Myers Squibb Company BMY 4.36%
Novartis AG NOVN 3.66%
Eli Lilly and Co LLY 3.64%
Regeneron Pharmaceuticals Inc REGN 3.36%
Eisai Co Ltd 4523 3.09%
Abbott Laboratories ABT 2.88%
Boston Scientific Corp BSX 2.72%

Other relevant VGHCX comparisons

You may also want to check out the following VGHCX comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

XLV description

The Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index. Under normal market conditions, the fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.

XLV performance & returns

YTD Return 8.25%
1-Month Return 2.30%
3-Month Return 2.37%
1-Year Return 14.12%
3-Year Return 12.45%
5-Year Return 10.66%
10-Year Return 15.38%
XLV expense ratio is 0.13%.

XLV holdings

Top 10 Holdings (51.64% of Total Assets)

Name Symbol % Assets
Johnson & Johnson JNJ 9.88%
UnitedHealth Group Inc UNH 7.47%
Merck & Co Inc MRK 5.29%
Pfizer Inc PFE 5.14%
Abbott Laboratories ABT 4.86%
Thermo Fisher Scientific Inc TMO 4.40%
AbbVie Inc ABBV 3.90%
Amgen Inc AMGN 3.75%
Medtronic PLC MDT 3.52%
Danaher Corp DHR 3.43%

Other relevant XLV comparisons

You may also want to check out the following XLV comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.

7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15 a month, without ads. Start a free trial. Go ad free!

Follow Us